Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Does Vaxart Still Have a Future?
08:08am, Wednesday, 10'th Feb 2021
The short answer: Yes.
Short-Sellers Just Won Their Bet on This Vaccine Stock
06:45am, Saturday, 06'th Feb 2021
The stock lost more than half its value in one trading session.
Why Vaxart Soared 109.8% In January
02:53pm, Friday, 05'th Feb 2021
Hope for an oral COVID-19 vaccine remains alive.
Is There Any Hope for Vaxart Stock?
07:03am, Friday, 05'th Feb 2021
This small-cap biotech just published clinical data for its experimental coronavirus vaccine, and investors are not happy.
Vaxart: Stock Drop Following Phase 1 Data For Oral COVID-19 Vaccine Is A Buying Opportunity
12:23pm, Thursday, 04'th Feb 2021
On Feb 3, Vaxart announced "Positive" Preliminary Data from its Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate. Vaxart reported that the study reached primary and seconda
Vaxart Disappoints With Coronavirus Vaccine Trial Update
10:09am, Thursday, 04'th Feb 2021
Results from a phase 1 study show that the biotech's vaccine candidate, VXA-CoV2-1, falls short in one crucial area.
What's Next for Vaxart After Its Massive Meltdown?
05:52am, Thursday, 04'th Feb 2021
The biotech really needs some good news.
Why Vaxart Stock Crashed Today
08:29pm, Wednesday, 03'rd Feb 2021
The coronavirus vaccine maker reported disappointing clinical trial results.
Biotech Bonanza: COVID Launches Science at Warp Speed
07:41pm, Wednesday, 03'rd Feb 2021
From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.
VXRT Stock Price Falls 57.78%: Why It Happened
05:29pm, Wednesday, 03'rd Feb 2021
The stock price of Vaxart Inc (NASDAQ: VXRT) fell by 57.78%. This is why it happened.
VXRT Stock: What To Know As Covid-19 Play Vaxart Plummets
04:57pm, Wednesday, 03'rd Feb 2021
Following short-squeeze hopes on Tuesday, Vaxart stock was down Wednesday on news of preliminary Phase I vaccine trial results. The post VXRT Stock: What To Know As Covid-19 Play Vaxart Plummets appea
Vaxart plummets 62% after its oral COVID-19 vaccine fails to produce antibodies (VXRT)
12:24pm, Wednesday, 03'rd Feb 2021
Vaxart said it observed positive preliminary data from its phase 1 clinical trial of its oral COVID-19 vaccine candidate, but investors weren't buying it. Shares of Vaxart crashed as much as 62% on We
Lifted by a Short Squeeze, Vaxart Stock Sinks on Lackluster Vaccine News
11:28am, Wednesday, 03'rd Feb 2021
The stock had risen fourfold from late December through Tuesday. It was down 50% on Wednesday.
Vaxart's stock falls 42% after disclosing preliminary results from early-stage COVID-19 vaccine study
08:57am, Wednesday, 03'rd Feb 2021
Shares of Vaxart Inc. tumbled 42.9% in premarket trading on Wednesday after the company said its oral COVID-19 vaccine candidate was well-tolerated in a Phase 1 clinical trial but it did not generate
Vaxart says its oral Covid vaccine produced promising results in early trial
08:30am, Wednesday, 03'rd Feb 2021
The vaccine, which comes in the form of a small tablet, generated a type of T-cell responsible for destroying virus-infected cells in about 75% of volunteers.
